Prevalence of Lung Cancer Screening in the US, 2022 is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3R01CA277756-02S1
Applying causal inference methods to improve estimation of the real-world benefits and harms of lung cancer screening - NCI Diversity Supplement
European Commission
Grant: 251686
INCORPORATING EUROPEAN FUNDAMENTAL VALUES INTO ICT FOR AGEING: A VITAL POLITICAL, ETHICAL , TECHNOLOGICAL, AND INDUSTRIAL CHALLENGE
National Institutes of Health
Grant: 1R01CA251686-01
Comorbidity and Functional Status in a Population Undergoing Lung Cancer Screening
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
Keywords
Sustainable Development Goals